[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Quality Australian vaccine data", "description": "Western Australian Vaccine Safety Surveillance \u2013 Annual Report 2021 \n\nhttps://www.health.wa.gov.au/~/media/Corp/Documents/Health-for/Immunisation/Western-Australia-Vaccine-Safety-Surveillance-Annual-Report-2021.pdf\n\nReport describes adverse events following immunisation (AEFI)\n\nReported to Western Australian Vaccine Safety Surveillance (WAVSS) system\n\nFor vaccinations received in 2021. \n\nThe format of this Annual Report differs, to enable description of the impact of the program\n\nCOVID-19 vaccination started in February 2021\n\nIn 2021, Western Australia\n\n5,756,723 vaccine doses were administered,\n\nup from 2,071,167 in 2020. \n\nOf this amount, 3,948,673 were COVID-19 vaccines\n\nIn 2021, a significant increase in reports of AEFI\n\n10,726 individual AEFI reports in 2021, \n\nup from 270 in 2020.\n\n(200 reports from Influenza and routine vaccinations in 2021) \n\nOf these AEFI, (adverse events following immunisation)\n\n10,428 (97%) occurred after a COVID-19 vaccine\n\nSimilar volume of reports in the rest of Australia\n \n(as reported by the Therapeutic Goods Administration)\n\nhttps://www.tga.gov.au/resources/article?f[0]=type:189\n\nIn Western Australia\n\nTotal AEFI rate following a COVID-19 vaccine was 264.1 per 100,000 doses. \n\n26.41 per 10 thousand \n2.641 per thousand\n0.241%\n\nNon covid vaccinations, WA, 2021\n\n11.1 events per 100,000 doses\n\n0.0111%\n\nComparison with US in 2021\nVaccine Adverse Event Reporting System \nhttps://vaers.hhs.gov/data/datasets.html\n148.3 per 100,000 doses\n\nVaxzevria (AstraZeneca)\n\n306.1 per 100,000 doses\n\nComirnaty (Pfizer)\n\n244.8 per 100,000 doses\n\n(US, 122 per 100,000)\n\nSpikevax (Moderna)\n\n281.4 per 100,000 doses\n\n(US, 187 per 100,000)\n\nWhy the difference?\n\nThis likely reflects differences in the sensitivity of passive adverse event reporting systems between the two jurisdictions. \n\nSome of the important AEFI that have been specifically monitored\n\nTGA-coordinated national surveillance vaccine safety program\n\nAnaphylaxis\n\nThrombosis with thrombocytopaenia syndrome (TTS)\n\nImmune thrombocytopenic purpura (ITP)\n\nGuillain-Barre\u0301 syndrome (GBS)\n\nMyocarditis\n\nPericarditis\n\nMyopericarditis\n\nChest pain\n\nDeep venous thrombosis\n\nPulmonary embolism\n\nBell\u2019s palsy\n\nIn 2021\n\n1,125 appointments made at the adult vaccine safety clinic at Sir Charles Gairdner Hospital, \n\nup from seven in 2020. \n\n439 appointments made at the Perth Children\u2019s Hospital specialist immunisation clinic, \n\nup from 214 in 2020.", "link": "https://www.youtube.com/watch?v=1l6Q2r5VWLo", "date_published": "2023-07-13T12:54:50+00:00", "persistent": false, "dead": false, "artist": null, "album": null, "user": null, "language": "en-UK", "thumbnail": "https://i2.ytimg.com/vi/1l6Q2r5VWLo/hqdefault.jpg"}]